{"url_path":"/sec/vxrt/8-k/2026-07-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/72444/0001213900-26-074576-index.html","accession_number":"0001213900-26-074576","cik":"0000072444","ticker":"VXRT","issuer_name":"Vaxart, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/72444/0001213900-26-074576-index.html","primary_entity_key":"0000072444","primary_entity_name":"Vaxart, Inc."},"word_count":91,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n \n\n*(d) Exhibits.*\n\n \n\nExhibit No.\n \nDescription\n\n10.1\n \n[Cooperation Agreement, dated July 1, 2026](ea029670901ex10-1.htm)\n\n99.1*\n \n[Vaxart, Inc. Press Release dated July 1, 2026](ea029670901ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n*Furnished herewith.\n\n \n\n3\n\n \n\n \n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements of the Securities\nExchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly\nauthorized.\n\n \n\nDate: July 1, 2026\n**VAXART, INC.**\n\n \n \n\n \n*/s/*Steven Lo\n\n \nSteven Lo\n\n \nPresident and Chief Executive Officer\n\n \n\n4"}